Drug Type Small molecule drug |
Synonyms Disufenton/acetylcysteine, Disufenton/N-acetylcysteine, HPN-07/NAC + [2] |
Target |
Mechanism Free radicals inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H15NO7S2 |
InChIKeyOVTCHWSLKGENKP-UHFFFAOYSA-N |
CAS Registry168021-77-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hearing Loss, Sensorineural | Phase 1 | US | - | |
Brain Injuries, Traumatic | Preclinical | US | - | 04 Feb 2020 |
Tinnitus | Preclinical | US | 10 Jul 2018 |